Cargando…

A Case of Chemotherapy-Refractory “THRLBCL like Transformation of NLPHL” Successfully Treated with Lenalidomide

Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a subtype of nonclassical Hodgkin lymphoma (HL). It resembles non-Hodgkin lymphoma (NHL), by expressing classic B cell markers such as CD20 and CD79a however lacks definitive HL markers (such as CD15 and CD30). T cell histiocyte-rich large B...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siricilla, Mamatha, Irwin, Lydia, Ferber, Andres
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818959/ https://www.ncbi.nlm.nih.gov/pubmed/29552367 http://dx.doi.org/10.1155/2018/6137454

Ejemplares similares

P019: Unfavorable prognostic value of the predominance of THRLBCL-like histopathological growth patterns in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL)
por: Dorokhina, Elena, et al.
Publicado: (2022)

P007: Comparative efficacy of the R-BEACOPP-14 and R-CHOP regimens in the treatment of patients with advanced stages of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with THRLBCL-like histopathological growth patterns in the tumor biopsy
por: Dorokhina, Elena, et al.
Publicado: (2022)

P033: Clinical significance of the severity of THRLBCL-like areas in nodular lymphocyte predominant Hodgkin lymphoma
por: Shupletsova, Irirna, et al.
Publicado: (2022)

Thymic Carcinoma Presenting as Disseminated Intravascular Coagulation
por: Siricilla, Mamatha, et al.
Publicado: (2014)

Successful use of lenalidomide to treat refractory acquired von Willebrand disease associated with monoclonal gammopathy
por: Green, Allen, et al.
Publicado: (2022)

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with CD30-positive lymphocyte-predominant (LP) cells
por: Seliem, Rania M., et al.
Publicado: (2011)

Successful Control of Acute Myelofibrosis with Lenalidomide
por: Vassilopoulos, G., et al.
Publicado: (2010)

P1092: NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA (NLPHL): HISTOLOGYCAL AND CLINICAL REVIEW IN A SINGLE CENTRE.
por: Rámila, E., et al.
Publicado: (2022)

A case of myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) successfully treated with lenalidomide
por: Islam, Anwarul
Publicado: (2015)

Gamma heavy chain disease complicated by pulmonary hypertension, which was successfully treated with lenalidomide
por: Shibata, Sho, et al.
Publicado: (2020)

Case Report: Successful Management of a Refractory Plasmablastic Lymphoma Patient With Tislelizumab and Lenalidomide
por: Cheng, Lili, et al.
Publicado: (2021)

Successful Management of Severe Recalcitrant Pemphigus Vulgaris with Lenalidomide
por: Jain, Akshay Kumar, et al.
Publicado: (2022)

Lenalidomide for the treatment of relapsed and refractory multiple myeloma
por: van de Donk, Niels WCJ, et al.
Publicado: (2012)

PSA Response to Lenalidomide Therapy in a Pre-Treated Patient with Metastatic Prostate Cancer Refractory to Hormones and Chemotherapy: A Case Report
por: Gasent Blesa, Joan Manel, et al.
Publicado: (2012)

Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens
por: Botta, Cirino, et al.
Publicado: (2021)

Refractory Sweet's syndrome successfully treated with rituximab
por: Seminario-Vidal, Lucia, et al.
Publicado: (2015)

Refractory Celiac Disease Successfully Treated With Azathioprine
por: Iqbal, Umair, et al.
Publicado: (2017)

Refractory pemphigus vulgaris successfully treated with ofatumumab
por: Klufas, Daniel M., et al.
Publicado: (2020)

Complete response associated with lenalidomide and celecoxib in a case of primary refractory Hodgkin lymphoma
por: Garcia-Recio, Marta, et al.
Publicado: (2018)

Safety and Efficacy of Lenalidomide in Relapsed or Refractory Multiple Myeloma
por: Alegre, Adrian, et al.
Publicado: (2011)

Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus
por: Cortés-Hernández, Josefina, et al.
Publicado: (2012)

How to Manage Patients with Lenalidomide-Refractory Multiple Myeloma
por: de Arriba de la Fuente, Felipe, et al.
Publicado: (2022)

The identification of TCF1(+) progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade
por: Tabanelli, Valentina, et al.
Publicado: (2022)

Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX
por: Dimopoulos, Meletios A., et al.
Publicado: (2018)

Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
por: Krawczyk, Katarzyna, et al.
Publicado: (2014)

Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis Complicated by Massive Splenomegaly Treated with Lenalidomide Resulting in Resolution of Splenomegaly but Severe and Prolonged Pancytopenia
por: Taylor, Gordon, et al.
Publicado: (2013)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
por: Kim, You Lim, et al.
Publicado: (2014)

Refractory uraemic pleuropericarditis treated successfully with corticosteroid therapy
por: Lee, So-Young, et al.
Publicado: (2009)

Medically Refractory Lymphocytic Colitis Successfully Treated With Upadacitinib
por: Miyatani, Yusuke, et al.
Publicado: (2023)

Lenalidomide: An Alternative Treatment for Refractory Behçet’s Disease and Relapsing Polychondritis
por: Brazão, Sofia Gomes, et al.
Publicado: (2019)

Refractory postherpetic neuralgia in a multiple myeloma patient with lenalidomide maintenance therapy: a case report
por: Cao, Xueqin, et al.
Publicado: (2022)

Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide
por: Vaxman, Iuliana, et al.
Publicado: (2020)

Lenalidomide-Associated ITP
por: Herold, Christina I., et al.
Publicado: (2011)

Refractory Uveitis in Patient with Castleman Disease Successfully Treated with Tocilizumab
por: Oshitari, Toshiyuki, et al.
Publicado: (2012)

Refractory Lupus Panniculitis Treated Successfully with Rituximab: Two Cases
por: Gupta, Partisha, et al.
Publicado: (2020)

A Case of Refractory Polymyositis Successfully Treated With Abatacept Monotherapy
por: ÇAĞLAYAN, Mehmet, et al.
Publicado: (2020)

Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)
por: Hitz, F., et al.
Publicado: (2019)

Elevated eosinophil level predicted long time to next treatment in relapsed or refractory myeloma patients treated with lenalidomide
por: Suzuki, Kazuhito, et al.
Publicado: (2020)

A Remarkable Remission: Treating HMA Refractory Transforming MDS with Single-Agent Low-Dose Cytarabine Leading to an Ongoing Six-Year OS
por: Palmer, David, et al.
Publicado: (2020)

Efficacy of dose-reduced lenalidomide in patients with refractory or recurrent multiple myeloma
por: Schwamborn, Katharina, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_78ls7fpbgok2tj62ho7gdnoqmq